Grant Number:	7R01CA244569-05 Interpret this number
Primary Investigator:	Gayther, Simon
Organization:	University Of Texas Hlth Science Center
Project Title:	Characterizing Non-Coding Somatic and Germline Variant Interactions in Ovarian Cancer
Fiscal Year:	2024

ABSTRACT A fundamental goal of human genetics is to decipher the relationship between genotype and phenotype. Cancer is defined as a disease comprising a heritable genetic component that confers cancer predisposition and an acquired (somatic) component where disease is driven by an accumulation of genetic mutations leading to ever increasing deregulation of normal cellular functions. Population based genome wide association studies (GWAS) and whole genome sequencing (WGS) analyses have identified thousands of germline risk variants for ovarian cancer and somatic non-coding mutations involved in ovarian cancer development. Identifying genomic regions where there are interactions between germline and somatic variants may enable us to identify the critical drivers of disease. We have established an end-to-end pipeline that can efficiently evaluate the functional significance of thousands of genetic variants in disease at once. We have also established ex-vivo models of fallopian tube secretary epithelial cells (precursors of ovarian cancer) and in vitro 3D models of chemoresistant ovarian cancer. In this proposal, we plan to address provocative question #3 “Do genetic interactions between germline variations and somatic mutations contribute to differences in tumor evolution or response to therapy?” with the following specific aims: (1) Use computational approaches, to identify genomic regions where germline and somatic genetic variants converge to indicate shared target genes and regulatory networks driving ovarian cancer development; (2) Use chromosome conformation capture assays to validate interactions between regulatory targets and their target genes; (3) Use CRISPR/Cas9 screens to establish the functional significance of germline-somatic interacting regions in ovarian cancer development.




MSGene: a multistate model using genetic risk and the electronic health record applied to lifetime risk of coronary artery disease.
Authors: Urbut S.M. , Yeung M.W. , Khurshid S. , Cho S.M.J. , Schuermans A. , German J. , Taraszka K. , Paruchuri K. , Fahed A.C. , Ellinor P.T. , et al. .
Source: Nature Communications, 2024-06-07 00:00:00.0; 15(1), p. 4884.
EPub date: 2024-06-07 00:00:00.0.
PMID: 38849421
Related Citations

A comprehensive analysis of clinical and polygenic germline influences on somatic mutational burden.
Authors: Taraszka K. , Groha S. , King D. , Tell R. , White K. , Ziv E. , Zaitlen N. , Gusev A. .
Source: American Journal Of Human Genetics, 2024-02-01 00:00:00.0; 111(2), p. 242-258.
EPub date: 2024-01-10 00:00:00.0.
PMID: 38211585
Related Citations

A Polygenic Risk Score for Predicting Racial and Genetic Susceptibility to Prurigo Nodularis.
Authors: Vasavda C. , Wan G. , Szeto M.D. , Marani M. , Sutaria N. , Rajeh A. , Lu C. , Lee K.K. , Nguyen N.T.T. , Adawi W. , et al. .
Source: The Journal Of Investigative Dermatology, 2023 Dec; 143(12), p. 2416-2426.e1.
EPub date: 2023-05-26 00:00:00.0.
PMID: 37245863
Related Citations

A Polygenic Risk Score for Predicting Racial and Genetic Susceptibility to Prurigo Nodularis.
Authors: Vasavda C. , Wan G. , Szeto M.D. , Marani M. , Sutaria N. , Rajeh A. , Lu C. , Lee K.K. , Nguyen N.T.T. , Adawi W. , et al. .
Source: The Journal Of Investigative Dermatology, 2023 Dec; 143(12), p. 2416-2426.e1.
EPub date: 2023-05-26 00:00:00.0.
PMID: 37245863
Related Citations

MSGene: Derivation and validation of a multistate model for lifetime risk of coronary artery disease using genetic risk and the electronic health record.
Authors: Urbut S.M. , Yeung M.W. , Khurshid S. , Cho S.M.J. , Schuermans A. , German J. , Taraszka K. , Fahed A.C. , Ellinor P. , Trinquart L. , et al. .
Source: Medrxiv : The Preprint Server For Health Sciences, 2023-11-08 00:00:00.0; , .
EPub date: 2023-11-08 00:00:00.0.
PMID: 37986972
Related Citations

Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary.
Authors: Moon I. , LoPiccolo J. , Baca S.C. , Sholl L.M. , Kehl K.L. , Hassett M.J. , Liu D. , Schrag D. , Gusev A. .
Source: Nature Medicine, 2023-08-07 00:00:00.0; , .
EPub date: 2023-08-07 00:00:00.0.
PMID: 37550415
Related Citations

Genotype error due to low-coverage sequencing induces uncertainty in polygenic scoring.
Authors: Petter E. , Ding Y. , Hou K. , Bhattacharya A. , Gusev A. , Zaitlen N. , Pasaniuc B. .
Source: American Journal Of Human Genetics, 2023-08-03 00:00:00.0; 110(8), p. 1319-1329.
EPub date: 2023-07-24 00:00:00.0.
PMID: 37490908
Related Citations

Germline mechanisms of immunotherapy toxicities in the era of genome-wide association studies.
Authors: Gusev A. .
Source: Immunological Reviews, 2023-07-28 00:00:00.0; , .
EPub date: 2023-07-28 00:00:00.0.
PMID: 37515388
Related Citations

Opportunities and Challenges with Artificial Intelligence in Genomics.
Authors: Kurant D.E. .
Source: Clinics In Laboratory Medicine, 2023 Mar; 43(1), p. 87-97.
EPub date: 2022-12-13 00:00:00.0.
PMID: 36764810
Related Citations

Germline cancer gene expression quantitative trait loci are associated with local and global tumor mutations.
Authors: Liu Y. , Gusev A. , Kraft P. .
Source: Cancer Research, 2023-02-06 00:00:00.0; , .
EPub date: 2023-02-06 00:00:00.0.
PMID: 36745477
Related Citations

Utilizing Electronic Health Records (EHR) and Tumor Panel Sequencing to Demystify Prognosis of Cancer of Unknown Primary (CUP) patients.
Authors: Moon I. , LoPiccolo J. , Baca S.C. , Sholl L.M. , Kehl K.L. , Hassett M.J. , Liu D. , Schrag D. , Gusev A. .
Source: Research Square, 2023-01-10 00:00:00.0; , .
EPub date: 2023-01-10 00:00:00.0.
PMID: 36711812
Related Citations

Germline variants associated with toxicity to immune checkpoint blockade.
Authors: Groha S. , Alaiwi S.A. , Xu W. , Naranbhai V. , Nassar A.H. , Bakouny Z. , El Zarif T. , Saliby R.M. , Wan G. , Rajeh A. , et al. .
Source: Nature Medicine, 2022-12-16 00:00:00.0; , .
EPub date: 2022-12-16 00:00:00.0.
PMID: 36526723
Related Citations

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors.
Authors: Nassar A.H. , Adib E. , Abou Alaiwi S. , El Zarif T. , Groha S. , Akl E.W. , Nuzzo P.V. , Mouhieddine T.H. , Perea-Chamblee T. , Taraszka K. , et al. .
Source: Cancer Cell, 2022-10-10 00:00:00.0; 40(10), p. 1161-1172.e5.
EPub date: 2022-09-29 00:00:00.0.
PMID: 36179682
Related Citations

Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation.
Authors: Baca S.C. , Singler C. , Zacharia S. , Seo J.H. , Morova T. , Hach F. , Ding Y. , Schwarz T. , Huang C.F. , Anderson J. , et al. .
Source: Nature Genetics, 2022 Sep; 54(9), p. 1364-1375.
EPub date: 2022-09-07 00:00:00.0.
PMID: 36071171
Related Citations

DeCAF: a novel method to identify cell-type specific regulatory variants and their role in cancer risk.
Authors: Kalita C.A. , Gusev A. .
Source: Genome Biology, 2022-07-08 00:00:00.0; 23(1), p. 152.
EPub date: 2022-07-08 00:00:00.0.
PMID: 35804456
Related Citations

Allelic imbalance of chromatin accessibility in cancer identifies candidate causal risk variants and their mechanisms.
Authors: Grishin D. , Gusev A. .
Source: Nature Genetics, 2022 Jun; 54(6), p. 837-849.
EPub date: 2022-06-13 00:00:00.0.
PMID: 35697866
Related Citations

Somatic mutational profiles and germline polygenic risk scores in human cancer.
Authors: Liu Y. , Gusev A. , Heng Y.J. , Alexandrov L.B. , Kraft P. .
Source: Genome Medicine, 2022-02-11 00:00:00.0; 14(1), p. 14.
EPub date: 2022-02-11 00:00:00.0.
PMID: 35144655
Related Citations

H3K27ac HiChIP in prostate cell lines identifies risk genes for prostate cancer susceptibility.
Authors: Giambartolomei C. , Seo J.H. , Schwarz T. , Freund M.K. , Johnson R.D. , Spisak S. , Baca S.C. , Gusev A. , Mancuso N. , Pasaniuc B. , et al. .
Source: American Journal Of Human Genetics, 2021-12-02 00:00:00.0; 108(12), p. 2284-2300.
EPub date: 2021-11-24 00:00:00.0.
PMID: 34822763
Related Citations

Constructing germline research cohorts from the discarded reads of clinical tumor sequences.
Authors: Gusev A. , Groha S. , Taraszka K. , Semenov Y.R. , Zaitlen N. .
Source: Genome Medicine, 2021-11-08 00:00:00.0; 13(1), p. 179.
EPub date: 2021-11-08 00:00:00.0.
PMID: 34749793
Related Citations

Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms.
Authors: Shetty A. , Seo J.H. , Bell C.A. , O'Connor E.P. , Pomerantz M.M. , Freedman M.L. , Gusev A. .
Source: American Journal Of Human Genetics, 2021-11-04 00:00:00.0; 108(11), p. 2071-2085.
EPub date: 2021-10-25 00:00:00.0.
PMID: 34699744
Related Citations

Immunotherapy-Mediated Thyroid Dysfunction: Genetic Risk and Impact on Outcomes with PD-1 Blockade in Non-Small Cell Lung Cancer.
Authors: Luo J. , Martucci V.L. , Quandt Z. , Groha S. , Murray M.H. , Lovly C.M. , Rizvi H. , Egger J.V. , Plodkowski A.J. , Abu-Akeel M. , et al. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2021-09-15 00:00:00.0; 27(18), p. 5131-5140.
EPub date: 2021-07-08 00:00:00.0.
PMID: 34244291
Related Citations

CDKN2A Alterations and Response to Immunotherapy in Solid Tumors.
Authors: Adib E. , Nassar A.H. , Akl E.W. , Abou Alaiwi S. , Nuzzo P.V. , Mouhieddine T.H. , Sonpavde G. , Haddad R.I. , Mouw K.W. , Giannakis M. , et al. .
Source: Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research, 2021-07-15 00:00:00.0; 27(14), p. 4025-4035.
EPub date: 2021-06-01 00:00:00.0.
PMID: 34074656
Related Citations

Transcription factors in epithelial ovarian cancer: histotype-specific drivers and novel therapeutic targets.
Authors: Nameki R. , Chang H. , Reddy J. , Corona R.I. , Lawrenson K. .
Source: Pharmacology & Therapeutics, 2021 04; 220, p. 107722.
EPub date: 2020-11-01 00:00:00.0.
PMID: 33137377
Related Citations

Germline Testing Data Validate Inferences of Mutational Status for Variants Detected From Tumor-Only Sequencing.
Authors: Jalloul N. , Gomy I. , Stokes S. , Gusev A. , Johnson B.E. , Lindeman N.I. , Macconaill L. , Ganesan S. , Garber J.E. , Khiabanian H. .
Source: Jco Precision Oncology, 2021; 5, .
EPub date: 2021-11-17 00:00:00.0.
PMID: 34820595
Related Citations